According to a market report by Lucintel, the future of the global digital diabetes management market looks promising with opportunities in the hospital, home setting, and diagnostic center markets. The global digital diabetes management market is expected to reach an estimated $31 billion by 2030 with a CAGR of 10.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of diabetes, technological advancements, and growing adoption of cloud-based enterprise solutions for diabetes management.
In this market, wearable devices and handheld devices are the major
segments of digital diabetes management market by type.
Lucintel forecasts that wearable devices will remain the larger segment
over the forecast period due to growing adoption of smart insulin pumps and
insulin patches for self-insulin delivery for the management of diabetes.
Within this market, hospitals will remain the largest segment due to
increasing adoption of digital technologies for remote patient monitoring and
easy availability of advanced digital diabetes management tools in hospitals.
North America is expected to witness highest growth over the forecast
period due to the increasing demand of connected diabetes management devices,
surging adoption of diabetes management and obesity apps, and growing awareness
on self-diabetes management in the region.
Abbott Laboratories, Medtronic, F. Hoffmann-La Roche, Bayer, Lifescan, Dexcom, Sanofi, Insulet Corporation, Ascensia Diabetes Care Holdings, and B Braun Melsungen are the major suppliers in the digital diabetes management market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056
or write us at helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
10. Stretcher Market
No comments:
Post a Comment